Researchers from the University of Cologne have developed an AI-based digital pathology platform for lung cancer analysis. This innovative platform automates the examination of tissue samples, significantly enhancing the speed and accuracy of diagnoses. The study, published in Cell Reports Medicine, highlights the potential of AI to extract critical information from pathological samples that traditional methods cannot achieve.
The platform not only improves diagnostic quality but also aids in creating new clinical tools for personalized therapy. By validating the platform with multiple institutes across Germany, Austria, and Japan, the research team aims to demonstrate its broad applicability. This advancement represents a significant step forward in the digital transformation of pathology, particularly in the fight against lung cancer.
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.